Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
索拉非尼辅助治疗预防肝细胞癌复发的分子预测因子及3期STORM试验中的预后因素
期刊:Gut
影响因子:25.8
doi:10.1136/gutjnl-2018-316408
Pinyol, Roser; Montal, Robert; Bassaganyas, Laia; Sia, Daniela; Takayama, Tadatoshi; Chau, Gar-Yang; Mazzaferro, Vincenzo; Roayaie, Sasan; Lee, Han Chu; Kokudo, Norihiro; Zhang, Zhongyang; Torrecilla, Sara; Moeini, Agrin; Rodriguez-Carunchio, Leonardo; Gane, Edward; Verslype, Chris; Croitoru, Adina Emilia; Cillo, Umberto; de la Mata, Manuel; Lupo, Luigi; Strasser, Simone; Park, Joong-Won; Camps, Jordi; Solé, Manel; Thung, Swan N; Villanueva, Augusto; Pena, Carol; Meinhardt, Gerold; Bruix, Jordi; Llovet, Josep M